Stefano Buono
InvestorFounder at Elysia Capital · Chairman of The Board Of Directors at LIFTT
Turin, Piedmont, Italy
Find your path to Stefano
170 people in our graph share verified history with Stefano — schools, employers, funds. One of them is your warm intro.
Federico GaliziaunlockedStefano: together at Università degli Studi di Torino (1985–1991)
×5Stefano: together at CERN
×6Stefano: together at Università degli Studi di Torino
About
Stefano Buono is the founder and CEO of newcleo and chairman of the board at LIFTT, Trained Therapeutics, and Planet Smart City. He is also a private investor and founder of Elysia Capital, a single family office based in London and Turin that focuses on social impact investments in sustainable innovation, wellbeing, education, art, and culture.
Experience
- newcleoFounder and Chief Executive Officercurrent2021 — present
- Order of MaltaCounsellor of the Grand Chancellorcurrent2025 — present
- Trained TherapeuticsChairman of the Boardcurrent2025 — presentOss, North Brabant, Netherlands
- Economic Diplomacy (Ministry of Foreign and European Affairs of the Slovak Republic)Honorary Consul for Piedmont of the Slovak Republiccurrent2024 — present
- LIFTT SpaChairman of The Board Of Directorscurrent2019 — presentTorino, Italy
- Planet Smart CityChairman of the board of Directorscurrent2018 — presentLondon Area, United Kingdom
- Elysia CapitalCo-Foundercurrent2018 — presentTurin, Piedmont, Italy
- Gauss FusionMember of The Supervisory Board2023 — 2026Hanau am Main, Hesse, Germany
- Advanced Accelerator ApplicationsAdvisor2018 — 2021
- Advanced Accelerator ApplicationsChief Executive Officer2002 — 2018
- Abeona Therapeutics Inc.Director Board Of Directors2018 — 2020New York City Metropolitan Area
- CERNScientific Associate1991 — 2002Geneva, Geneva, Switzerland
- CRS4Team Manager1996 — 2002Cagliari, Italy
Skills & more
Hardware Diagnostics87GMP28Radiopharmaceuticals15R&D89Clinical Trials19Drug Discovery11Sop2Oncology30Product Launch13Analytical Chemistry4Medical Imaging18Cancer7
+12 more
Sales EffectivenessManufacturingCapital EquipmentSalesScienceMedical DevicesCommercializationHealthcareFrenchManagementPharmaceutical IndustryCROLanguages English · French · Italian · Spanish
From Stefano's professional profile.
Colleagues at Elysia Capital
Frequently asked questions
- Who is Stefano Buono?
- Stefano Buono is the founder and CEO of newcleo and chairman of the board at LIFTT, Trained Therapeutics, and Planet Smart City. He is also a private investor and founder of Elysia Capital, a single family office based in London and Turin that focuses on social impact investments in sustainable innovation, wellbeing, education, art, and culture.
- Where does Stefano Buono work?
- Stefano Buono is Founder at Elysia Capital.
- Where did Stefano Buono go to school?
- Stefano Buono studied at Università degli Studi di Torino (Master's degree, Physics).
Same school
Also attended Università degli Studi di Torino64
Andrea Di CamilloFounder, CEO & Managing Partner at P101 VenturesMarco PrunottoInvestor at MedicxiStefano LomartireInvestment Executive at Apposite CapitalAndrea SilvelloBanking & Real Estate at Proximity CapitalFederico GaliziaIFC Vice President and Chief Risk Officer at International Finance CorporationAlberto CrestoGeneral Partner at Lunar Ventures
+ 58 more
Shared employers
Also worked at Planet Smart City2
Also worked at Advanced Accelerator Applications1
Also worked at Abeona Therapeutics Inc.2
Also worked at CERN71
Elizabeth YinCo-founder and General Partner at Hustle Fund, a pre-seed fund for software entrepreneursRuben PauwelsInvestor at AngelwiseFilip SirokyGeneral Partner at MitonCHarald NiederGeneral Partner at redalpineMike MillerPartner at Liquid VenturesMagnus HambletonInvestor at byFounders
+ 65 more